Invitro Medical Solutions Private Limited

Invitro Medical Solutions Private Limited - healthcare in New Delhi, Delhi, India. Directors, charges & compliance details.
CIN U74899DL1987PTC028913 Incorporated 13 August 1987 ROC Delhi HQ New Delhi, Delhi, India
Struck Off Private Limited Company healthcare
Data last updated
Revenue · FY 2020
₹95,665
▲ 266% YoY
Net loss · FY 2020
₹1.68 Lakh
Net margin -175.9%
EBITDA · FY 2020
-₹46,155
EBITDA margin -48.2%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹13.86 Lakh
Issued & subscribed
Company age
39 yrs
Est. 1987
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Invitro Medical Solutions Private Limited

Data last updated:

Invitro Medical Solutions Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 13 August 1987.

The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1987PTC028913. Its GSTIN is 07AABCH1581P1Z9 (Delhi).

The company had an authorised share capital of ₹25 Lakh and a paid-up capital of ₹13.86 Lakh. It was led by directors Yogita Singh (Managing Director) and Leepakshi Dhingra.

Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Lower Ground B – 377 Meera Bagh Paschim Vihar, New Delhi, Delhi, India – 110063.

As per the financials filed for FY 2020, the company reported a revenue of ₹95,665, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.68 Lakh (net margin -175.9%) and EBITDA of -₹46,155 (EBITDA margin -48.2%). Revenue has declined at a compounded annual rate (CAGR) of 65% over three years and 49% over five years.

Court records list 1 case involving the company, including 1 filed against it.

The last known website on record is ivmsindia.com.

Company details

CIN U74899DL1987PTC028913
Registration Number 028913
Incorporation Date 13 August 1987
ROC Delhi
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 31 December 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Compliant

Contact details

Invitro Medical Solutions Private Limited's registered office is in New Delhi, Delhi. Its website is ivmsindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Lower Ground B – 377 Meera Bagh Paschim Vihar, New Delhi, Delhi, India – 110063
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Invitro Medical Solutions Private Limited, buy the company report.

Comprehensive company report
Invitro Medical Solutions Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Invitro Medical Solutions is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Invitro Medical Solutions Private Limited, buy the company report.

Financials of Invitro Medical Solutions Private Limited

FY 2020 filings available

Invitro Medical Solutions Private Limited reported revenue of ₹95,665 (up 266% YoY) for FY 2020.

Revenue · FY 2020
₹95,665 ▲ 266%
Net loss · FY 2020
₹1.68 Lakh margin -175.9%
EBITDA · FY 2020
-₹46,155 margin -48.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 266%
3 years · compounded
▼ 65%
5 years · compounded
▼ 49%
EBITDA CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 71%
5 years · compounded
▼ 16%

Revenue rose 266% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 49%. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹46,155
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.68 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin-48.2%
Net Profit Margin-175.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Invitro Medical Solutions Private Limited, buy the company report.

Board of directors of Invitro Medical Solutions Private Limited

Invitro Medical Solutions has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Leepakshi DhingraDirector25 Feb 20206 Years 7 MonthsAs last reported
Yogita SinghManaging Director25 Feb 20206 Years 7 MonthsAs last reported

Auditor

Invitro Medical Solutions Private Limited is audited by RSMA & Company for the financial year 2015.

Auditor firmFinancial yearFirm registration number
RSMA & CompanyFY 2015

Shareholding

The shareholding of Invitro Medical Solutions Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Invitro Medical Solutions Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Invitro Medical Solutions Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Invitro Medical Solutions has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AABCH1581P1Z9DelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Invitro Medical Solutions Private Limited, buy the company report.

Recent activity

Invitro Medical Solutions Private Limited has 5 board changes on record since 2020: 2 appointments and 3 cessations. The latest: Geeta Sharma ceased to be Director on 05 Mar 2020.

AGM
Invitro Medical Solutions Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Filing
Invitro Medical Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Delhi.
Ceased
Geeta Sharma ceased to be Director.
Ceased
Rajendra Sharma ceased to be Director.
Ceased
Ravinder Narula ceased to be Director.
Appointed
Leepakshi Dhingra was appointed as Director.
Appointed
Yogita Singh was appointed as Managing Director.
Incorporation
13 Aug 1987
Invitro Medical Solutions Private Limited was registered on 13 Aug 1987 with Roc Delhi & aged 39 years 2 months as per MCA records.

Frequently asked questions

Invitro Medical Solutions has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Invitro Medical Solutions was a private limited company based in New Delhi, Delhi, India. The company worked in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 13 August 1987 and is registered under CIN U74899DL1987PTC028913. The company has been struck off by the Registrar of Companies and is no longer operational.

Invitro Medical Solutions had 2 directors:

The CIN (Corporate Identification Number) of Invitro Medical Solutions is U74899DL1987PTC028913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Invitro Medical Solutions is at Lower Ground B – 377 Meera Bagh Paschim Vihar, New Delhi, Delhi, India – 110063.

Invitro Medical Solutions was incorporated on 13 August 1987. It is registered with the Registrar of Companies, Delhi.

Invitro Medical Solutions can be reached through the website ivmsindia.com. Its registered office is in New Delhi, Delhi, India.

The latest financial statements of Invitro Medical Solutions on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.

The GSTIN of Invitro Medical Solutions is 07AABCH1581P1Z9, registered in Delhi.

Invitro Medical Solutions operated in the healthcare industry, in the diagnostic centers and pathology labs segment. It worked in this industry before it was struck off.